Related Experiment Video
Updated: Jul 29, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
A case of seasonal bipolar disorder exacerbated by Cushing's disease
Abdu'l-Missagh Ghadirian1, Sorana Marcovitz, Beverley E Pearson Murphy
1Department of Psychiatry, Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec, Canada. amghadirian@earthlink.net
Abstract:
While depression is common in Cushing's syndrome from whatever cause (pituitary, adrenal, or ectopic adrenocorticotropic hormone-secreting tumor or hyperplasia, or exogenous administration of glucocorticoids) and hypercortisolemia is prevalent in major depression, any association between seasonal affective disorder and Cushing's syndrome is unknown. We present a case of seasonal bipolar disorder, gradually worsening for more than 9 years (1985-1994), accompanied by increasing osteoporosis, mild weight gain, and slight truncal obesity in a middle-aged woman. In January 1991, her seasonal affective disorder was successfully treated with light therapy, but in the following year, bipolar mood swings with a seasonal pattern emerged, which were refractory to light therapy and antidepressants but responsive to lithium. In August 1992, she became depressed despite a 1500-mg lithium daily dosage along with light therapy, and, in 1993, a diagnosis of Cushing's disease (Cushing's syndrome as a result of a pituitary adrenocorticotropic hormone-secreting tumor) was made. The pituitary tumor was removed in February 1994, and pituitary function was fully restored by 1996. While the symptoms of Cushing's syndrome subsided, her bipolar illness continued to require maintenance treatment with low doses of lithium but did not require light therapy.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Depressive Disorders: MDD and Dysthymia
Bipolar Disorder
Graves' Disease I: Introduction
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology

